BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8807126)

  • 1. Physical and psychosocial functioning of 117 survivors of bone marrow transplantation.
    Prieto JM; Saez R; Carreras E; Atala J; Sierra J; Rovira M; Batlle M; Blanch J; Escobar R; Vieta E; Gomez E; Rozman C; Cirera E
    Bone Marrow Transplant; 1996 Jun; 17(6):1133-42. PubMed ID: 8807126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood.
    Ishida Y; Kamibeppu K; Sato A; Inoue M; Hayakawa A; Shiobara M; Yabe H; Koike K; Adachi S; Yamashita T; Kanda Y; Okamoto S; Atsuta Y
    Int J Hematol; 2022 Nov; 116(5):787-797. PubMed ID: 36056987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep disruption among cancer patients following autologous hematopoietic cell transplantation.
    Nelson AM; Jim HSL; Small BJ; Nishihori T; Gonzalez BD; Cessna JM; Hyland KA; Rumble ME; Jacobsen PB
    Bone Marrow Transplant; 2018 Mar; 53(3):307-314. PubMed ID: 29269811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sertraline on complications and survival after hematopoietic stem-cell transplantation, a double-blind, placebo-controlled clinical study.
    Tavakoli-Ardakani M; Kheshti R; Maryam M
    Int J Hematol; 2017 Dec; 106(6):832-841. PubMed ID: 28815419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
    Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
    Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia.
    Kurosawa S; Yamaguchi T; Mori T; Kanamori H; Onishi Y; Emi N; Fujisawa S; Kohno A; Nakaseko C; Saito B; Kondo T; Hino M; Nawa Y; Kato S; Hashimoto A; Fukuda T
    Bone Marrow Transplant; 2015 Sep; 50(9):1241-9. PubMed ID: 26076127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: comparison with matched healthy group.
    Alaloul F; Brockopp DY; Andrykowski MA; Hall LA; Al Nusairat TS
    Support Care Cancer; 2015 Jul; 23(7):2157-64. PubMed ID: 25556704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates.
    Holmes HM; Des Bordes JK; Kebriaei P; Yennu S; Champlin RE; Giralt S; Mohile SG
    J Geriatr Oncol; 2014 Oct; 5(4):422-30. PubMed ID: 24835889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life assessment in multiple myeloma patients undergoing dose-reduced tandem autologous stem cell transplantation.
    Khalafallah A; McDonnell K; Dawar HU; Robertson I; Woods D
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011057. PubMed ID: 22220254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.
    Gupta SC; Kim JH; Kannappan R; Reuter S; Dougherty PM; Aggarwal BB
    Exp Biol Med (Maywood); 2011 Jun; 236(6):658-71. PubMed ID: 21565893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.
    Bevans MF; Mitchell SA; Barrett AJ; Bishop M; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L
    Health Qual Life Outcomes; 2011 Apr; 9():24. PubMed ID: 21496339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with self-reported physical and mental health after hematopoietic cell transplantation.
    Wingard JR; Huang IC; Sobocinski KA; Andrykowski MA; Cella D; Rizzo JD; Brady M; Horowitz MM; Bishop MM
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1682-92. PubMed ID: 20685400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation.
    DuHamel KN; Mosher CE; Winkel G; Labay LE; Rini C; Meschian YM; Austin J; Greene PB; Lawsin CR; Rusiewicz A; Grosskreutz CL; Isola L; Moskowitz CH; Papadopoulos EB; Rowley S; Scigliano E; Burkhalter JE; Hurley KE; Bollinger AR; Redd WH
    J Clin Oncol; 2010 Aug; 28(23):3754-61. PubMed ID: 20625129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Le RQ; Bevans M; Savani BN; Mitchell SA; Stringaris K; Koklanaris E; Barrett AJ
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1162-70. PubMed ID: 20302959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.
    Wong FL; Francisco L; Togawa K; Bosworth A; Gonzales M; Hanby C; Sabado M; Grant M; Forman SJ; Bhatia S
    Blood; 2010 Mar; 115(12):2508-19. PubMed ID: 20089962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.
    Pidala J; Anasetti C; Jim H
    Br J Haematol; 2010 Feb; 148(3):373-85. PubMed ID: 19919651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).
    Mitchell SA; Leidy NK; Mooney KH; Dudley WN; Beck SL; LaStayo PC; Cowen EW; Palit P; Comis LE; Krumlauf MC; Avila DN; Atlam N; Fowler DH; Pavletic SZ
    Bone Marrow Transplant; 2010 Apr; 45(4):762-9. PubMed ID: 19784078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life after allogeneic hematopoietic cell transplantation.
    Pidala J; Anasetti C; Jim H
    Blood; 2009 Jul; 114(1):7-19. PubMed ID: 19336756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.
    Wang XS; Shi Q; Williams LA; Cleeland CS; Mobley GM; Reuben JM; Lee BN; Giralt SA
    Cancer; 2008 Oct; 113(8):2102-9. PubMed ID: 18792065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.
    Syrjala KL; Kurland BF; Abrams JR; Sanders JE; Heiman JR
    Blood; 2008 Feb; 111(3):989-96. PubMed ID: 17878404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.